Trials / Conditions / Adult Attention Deficit Hyperactivity Disorder

Adult Attention Deficit Hyperactivity Disorder

11 registered clinical trials studyying Adult Attention Deficit Hyperactivity Disorder.

Status	Trial	Sponsor	Phase
Completed	Researching the Effectiveness of Attexis, a Digital Health Application for Adults With Attention Deficit Hyper NCT06221930	Gaia AG	N/A
Completed	Duration and Efficacy of Azstarys on Adult ADHD Symptoms and Executive Function in Early Evening NCT06000501	NYU Langone Health	Phase 4
Completed	The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity Disorder NCT03324581	Otsuka Pharmaceutical Development & Commercialization, Inc.	Phase 2
Completed	Clinical and Suicidal Features of Urban, Turkish Middle Age Depressive Patients With Comorbid ADHD NCT03721588	Bozyaka Training and Research Hospital	—
Completed	Dasotraline Adult ADHD Study NCT02276209	Sumitomo Pharma America, Inc.	Phase 3
Completed	Open-label Safety Study in Adults With ADHD NCT02160262	Sumitomo Pharma America, Inc.	Phase 3
Completed	Essential Fatty Acids in Adult ADHD NCT01798381	Universität des Saarlandes	Phase 3
Completed	Adult Attention Deficit Hyperactivity Disorder NCT01692782	Sumitomo Pharma America, Inc.	Phase 2
Completed	Efficacy and Safety Eval of Guanfacine Hydrochloride in Combination With Psychostimulants in Adults (18-65). NCT02141113	Rochester Center for Behavioral Medicine	Phase 4
Completed	Integrated Diagnosis and Treatment of Adults With Attention-deficit/Hyperactivity Disorder NCT01615679	Medice Arzneimittel Pütter GmbH & Co KG	—
Completed	Study of Adderall-XR for the Treatment of Adult Attention Deficit Hyperactivity Disorder and Cocaine Dependenc NCT00553319	New York State Psychiatric Institute	Phase 2 / Phase 3